|
Product complaint # (b)(4).Additional product code: hwc, screw, fixation, bone.A review of the device history record has been completed.(b)(4).The device has been received, the investigation is in progress, no conclusion could be drawn at the time of filing this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: e3 h3, h4, h6: manufacturing location: monument.Manufacturing date: july 12, 2021.Part: 04.233.038s, rfn/10mm/380mm 5 degree bend/pe inlay/sterile.Lot: 131p424 (sterile).Production order traveler met all inspection acceptance criteria.Inspection sheet, in-process / inspect dimensional / final met all inspection acceptance criteria.Inspection sheet, rfn assembly inspection met all inspection acceptance criteria.Packaging bom was reviewed and determined to be conforming with no deviations to normal packaging identified.There was no packaging labeling log (pll) included in this device history record (dhr).Therefore, the pll for this lot could not be reviewed and the expiration date could not be notated.This lot met all dimensional and visual criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Component part(s) reviewed: part: 04.233.124.2y, poly inlay retrograde femoral.Lot: 96p8883.Production order traveler met all inspection acceptance criteria.Inspection sheet met all inspection acceptance criteria.Part: 21131, tialv*ri13.00.Lot: 62p4625.Inspection instruction met all inspection acceptance criteria.Product certification supplied by nf&m international inc.Was reviewed and determined to be conforming.Lot summary report met all inspection acceptance criteria.Raw material receiving / putaway checklist met all inspection acceptance criteria.The product was returned to us customer quality (cq) for evaluation.The us cq team conducted a visual inspection of the returned device.Visual analysis of the returned sample revealed that the rfna / 10 / 380 5 deg bend / sterile had broken across the proximal locking hole.The broken end of the nail was also returned.No other issues were identified.The dimensional inspection was performed and the device met specifications.The observed condition of the rfna / 10 / 380 5 deg bend / sterile was consistent with a random component failure that may have been caused by exposure to excessive/unintended forces.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.The overall complaint was confirmed as the rfna / 10 / 380 5 deg bend / sterile was observed to have broken postoperatively.While no definitive root cause could be determined from the available information, it is probable that the rfna / 10 / 380 5 deg bend / sterile was broken due to exposure to excessive/unintended forces.There was no indication that a design or manufacturing issue contributed to the complaint.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Drawing/specifications reviewed the following drawings reflecting the current and manufactured revisions were reviewed: retrograde femoral nail 9, 10mm diameter.Dimensional inspection: measured dimensions: diameter: conforming.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|